LexaGene Demonstrates a Simple and Inexpensive Multiplex PCR Chemistry with Shorter Lead Times for use on its MiQLab System
12 août 2021 07h45 HE
|
LexaGene Holdings Inc
First point-of-need, PCR system capable of using conventional probe-based chemistry or inexpensive, rapidly available SYBR Green chemistry BEVERLY, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE) -- LexaGene...
LexaGene’s MiQLab Detects Common Bioreactor Contaminant up to 300 Times Faster than Conventional Methods
20 juil. 2021 07h45 HE
|
LexaGene Holdings Inc
Mycoplasmas are thought to contaminate 15-80% of cell cultures worldwideMiQLab rapidly detected 100% of the tested mycoplasma samples within two hours, with no false positivesMiQLab can be used inside...
LexaGene Retains Wolf Greenfield Intellectual Property Law Firm
14 juil. 2021 07h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a molecular diagnostics company that develops a fully automated rapid pathogen...
LexaGene Launches 2nd Generation Bacterial and Drug Resistance Test to Better Meet the Diagnostic Needs of Veterinarians
07 juil. 2021 07h45 HE
|
LexaGene Holdings Inc
New panel offers extensive improvements for pathogen identification and drug resistance gene testing Increases targeted pathogens from 7 to 10 (140% increase)Increases targeted drug resistance genes...
LexaGene Advances Towards FDA Emergency Use Authorization
02 juil. 2021 07h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., July 02, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Announces Fourth Quarter and Full-Year End February 28, 2021, Financial Results
29 juin 2021 10h01 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., June 29, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Engages LaVoieHealthScience as Integrated Investor and Public Relations Agency of Record
28 juin 2021 07h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., June 28, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG), (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
New Sale of LexaGene’s MiQLab™ System Propels Early Diagnostic Testing in Veterinarian Practices
24 juin 2021 07h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., June 24, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG), a molecular diagnostics company that develops fully automated rapid pathogen detection systems,...
LexaGene’s MiQLab Offers Rapid Plague Detection for Bioterrorism Threats
17 juin 2021 07h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., June 17, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) a molecular diagnostics company, is pleased to announce that today, Dr. Jack Regan, CEO and...
LexaGene Closes Sale to Alpine Veterinary Hospital
14 juin 2021 07h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., June 14, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG), a molecular diagnostics company, announced the Company has sold another MiQLab™ System and the...